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PIntervention in Congenital Heart Disease
Long-Term Pulmonary Regurgitation Following
Balloon Valvuloplasty for Pulmonary Stenosis
Risk Factors and Relationship to Exercise Capacity
and Ventricular Volume and Function
David M. Harrild, MD, PHD, Andrew J. Powell, MD, Trang X. Trang, MPH, BS, Tal Geva, MD,
James E. Lock, MD, Jonathan Rhodes, MD, Doff B. McElhinney, MD
Boston, Massachusetts
Objectives This study sought to examine the prevalence and predictors of pulmonary regurgitation (PR) following balloon
dilation (BD) for pulmonary stenosis (PS) and to investigate its impact on ventricular volume and function, and
exercise tolerance.
Background Balloon pulmonary valvuloplasty relieves PS but can cause late PR. The sequelae of isolated PR are not well
understood.
Methods Patients were at least 7 years of age and 5 years removed from BD, and had no other form of congenital heart
disease or significant residual PS. Cardiac magnetic resonance imaging and exercise testing were performed
prospectively to quantify PR fraction, ventricular volumes and function, and exercise capacity.
Results Forty-one patients underwent testing a median of 13.1 years after BD. The median PR fraction was 10%; 14 pa-
tients (34%) had PR fraction 15%; 7 (17%) had PR 30%. PR fraction was associated with age at dilation (ln-
transformed, R  0.47, p  0.002) and balloon:annulus ratio (R  0.57, p  0.001). The mean right ventricu-
lar (RV) end-diastolic volume z-score was 1.8  1.9; RV dilation (z-score 2) was present in 14/35 patients
(40%). PR fraction correlated closely with indexed RV end-diastolic volume (R  0.79, p  0.001) and modestly
with RV ejection fraction (R  0.50, p  0.001). Overall, peak oxygen consumption (VO2) (% predicted) was be-
low average (92  17%, p  0.006). Patients with PR fraction 15% had significantly lower peak VO2 than
those with less PR (85  17% vs. 96  16%, p  0.03).
Conclusions Mild PR and RV dilation are common in the long term following BD. A PR fraction 15% is associated with
lower peak VO2, suggesting that isolated PR and consequent RV dilation are related to impaired exercise cardio-
pulmonary function. (J Am Coll Cardiol 2010;55:1041–7) © 2010 by the American College of Cardiology
Foundation










dittle is known about the pathophysiology of chronic isolated
ulmonary regurgitation (PR). Congenital pulmonary valve
ncompetence is extremely rare, with most published reports
onsisting of individual cases (1–3). In the largest published
eries, Shimazaki et al. (4) described long-term outcomes of 72
atients with this condition. Symptoms of heart failure were
ncommon at 20 years (6%), but the likelihood of developing
hem increased dramatically over time, and premature death
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009, accepted January 2, 2010.ccurred in 3 symptomatic patients. A growing number of
hildren and adults are subjected to long-term PR, including
hose with repaired conotruncal lesions as well as patients with
alvar pulmonary stenosis (PS) following balloon dilation
BD). In the context of this expanding population, the need to
nderstand the impact of chronic PR has become increasingly
mportant.
See page 1048
In this study, we evaluated patients previously treated for
ncomplicated valvar PS with percutaneous BD in an effort to
ain insight into the late physiologic effects of chronic, isolated
R. Percutaneous balloon pulmonary valvuloplasty was intro-
uced in 1982 (5) and subsequently became the first-line
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Long-Term PR After Pulmonary Valve Dilation March 9, 2010:1041–7number of reports have detailed
medium- and long-term outcomes
of this therapy. With rare excep-
tions (6), however, the primary
focus of these reports has been
freedom from recurrence of valvar
stenosis (7–11). In the present
study, we used cardiac magnetic
resonance (CMR) imaging and
exercise testing to investigate the
prevalence and physiologic impact
of long-term PR after balloon pul-
monary valvuloplasty for congeni-
tal valvar PS. Our primary goal
was to determine whether chronic
PR is associated with compro-
mised exercise cardiopulmonary
function in the absence of con-
founding factors (such as surgical
ventriculotomy, long-standing
pre-procedural cyanosis, or expo-
sure to cardiopulmonary bypass).
A secondary goal was to assess the
elationships between demographic and procedural factors at
alvuloplasty and late PR, and between PR and ventricular size
nd function.
ethods
atients. Subjects with valvar PS having undergone BD of
he pulmonary valve were identified from the database of the
ardiovascular program at Children’s Hospital Boston. In-
lusion criteria were: history of valvar PS treated with
ercutaneous balloon valvuloplasty; managed at our institu-
ion; age 7 years at the time of enrollment; and at least a
-year interval between the pulmonary valve dilation pro-
edure and enrollment. Patients were excluded if they had
ignificant residual PS (30 mm Hg gradient on last
vailable echo or CMR evaluation); other congenital heart
isease, including significant atrial septal defect; or any
istory of cardiac surgery. Eligible patients were contacted
y mail with an informational packet describing the study,
ollowed by a series of up to 3 telephone calls. Enrolled
atients were prospectively studied with CMR imaging and
xercise testing. This study was performed according to a
rotocol approved by the Committee for Clinical Investi-
ation at Children’s Hospital Boston. All study subjects
rovided written informed consent.
atheterization and balloon valvuloplasty. Balloon pul-
onary valvuloplasty was performed as previously described,
ith a target balloon:annulus diameter ratio (BAR) of 1.2 to
.4 (12). Catheterization reports from the pulmonary valve
ilation procedure were reviewed. Recorded data included:
ge at catheterization, initial right ventricular (RV) pressure,
he ratio of RV to systemic arterial or ventricular pressure,
Abbreviations
and Acronyms
BAR  balloon: annulus
ratio
BD  balloon dilation
CMR  cardiac magnetic
resonance
EF  ejection fraction




PS  pulmonary stenosis




VE/VCO2  ratio of minute
ventilation:carbon dioxide
production
VO2  oxygen consumptionhe diameter of the largest balloon used for valve dilation at taximal inflation, and the pulmonary valve annulus diam-
ter measured during systole (5). The BAR was calculated as
he ratio of these 2 diameters. For patients with data
issing from the catheterization report, measurements were
erformed by direct review of the angiograms by 1 of the
uthors (D.B.M.). In the event of multiple catheterizations
ith valve dilation, the largest BAR and the age at the first
atheterization procedure were used for analysis. The pul-
onary valve annulus diameter z-score was calculated rela-
ive to body surface area from published normative data
btained at our institution (13).
MR imaging. CMR was performed using a 1.5-Tesla
canner (Achieva, Philips Medical Systems, Best, the Neth-
rlands) and radiofrequency coils selected according to body
ize. All examinations were performed without sedation.
iventricular dimensions and function were assessed as
reviously described (14). Briefly, electrocardiogram-gated
reath-held steady-state free precession imaging was per-
ormed in the ventricular short-axis plane with 12 to 14
quidistant slices completely covering both ventricles. Flow
easurements were performed in the proximal main pul-
onary artery with a retrospectively gated velocity-encoded
ine MR pulse sequence during free breathing. CMR data
ere analyzed using commercially available software pack-
ges (QMASS version 6.2.3 and QFLOW version 4.1.7,
edis, Leiden, the Netherlands). Left ventricular (LV) and
V end-diastolic (maximal) and end-systolic (minimal)
olumes, mass at end diastole, stroke volume, and ejection
raction (EF) were measured as previously described (15).
or all patients, ventricular volumes were indexed to body
urface area. RV and LV end-diastolic volume z-scores were
alculated for males and females in whom published nor-
ative data are available (body surface area 1.25 m2 and
.0 m2, respectively) (15). An RV end-diastolic volume
-score 2 signified at least mild dilation. PR volume was
easured as the amount of retrograde flow in the main
ulmonary artery per cardiac cycle, and was indexed to body
urface area to yield a PR volume index (milliliters/square
eter/beat); the PR fraction was calculated as the retrograde
ow divided by the antegrade flow in the main pulmonary
rtery, expressed as a percentage (16). Tricuspid regurgita-
ion (TR) fraction, expressed as a percentage, was quantified
s: (100  TR volume)/TR inflow, where TR volume 
RV stroke volume LV stroke volume) PR volume; and
R inflow  RV stroke volume  PR volume.
xercise testing. Exercise testing was performed with a
rogressive symptom-limited protocol using a cycle (17) or
readmill (18) ergometer. Electrocardiographic monitoring
nd breath-by-breath expiratory gas analysis were per-
ormed using a CardiO2 exercise testing system (Medical
raphics Corp., Minneapolis, Minnesota). Cuff blood pres-
ure measurements and 12-lead electrocardiograms were
btained at 2- to 3-min intervals during exercise, at peak
xercise, and at 1, 3, and 5 min after exercise. Oxygen
aturation was also monitored by pulse oximetry throughout
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March 9, 2010:1041–7 Long-Term PR After Pulmonary Valve Dilationic measurements of forced vital capacity and volume of air
xhaled in the first second of forced expiration were ob-
ained. The exercise testing system was calibrated according
o manufacturer specifications prior to each test.
Peak exercise parameters were expressed as the percent-
ge of the predicted value for age, sex, and size. Normal data
ere taken from the following sources: age 17 years,
ooper and Weiler-Ravell (19); age 18 years, Jones (20).
utcome parameters included the percentage of predicted
alues for peak oxygen consumption (VO2), peak work rate,
eak heart rate, and O2 pulse (a measure of forward stroke
olume) (20); the slope of the minute ventilation:carbon
ioxide production ratio (VE/VCO2, an index of the effi-
iency of gas exchange during exercise [17]); and spiromet-
ic measurements. For peak VO2, peak work rate, O2 pulse,
nd heart rate, a subnormal value was defined as 85% of
he predicted value, in accordance with the 2003 American
horacic Society/American College of Chest Physicians
tatement on Cardiopulmonary Exercise Testing; normal
E/VCO2 was 29 (21,22).
ata analysis. The primary hypothesis was that higher PR
raction would be associated with lower percent predicted
eak VO2. The analysis was organized according to 3
utcome categories: PR fraction, ventricular volumes and
unction, and exercise function. The first outcome was PR
raction, which was considered a procedural outcome and
as treated both as a continuous variable and dichotomized
round 15% on the basis of receiver-operator curve analysis
or percent predicted peak VO2. Demographic and proce-
ural factors analyzed for association with PR fraction
ncluded age at the time of valvuloplasty (ln-transformed
nd dichotomized around 1 year), pre-intervention RV
ressure and RV:systemic pressure ratio, and BAR (contin-
ous and dichotomized around 1.4, the upper limit of the
sual target BAR range). For the second category of
utcomes, associations between PR and ventricular volumes
nd function were assessed. For the third category of
utcomes, relationships between the primary outcome (per-
ent predicted peak VO2) and CMR (PR fraction and
olume, RV and LV volumes and function) and demo-
raphic (age at intervention and follow-up, body mass
ndex, gender) factors were assessed. Procedural variables
ere not included in the analysis of exercise function based
n the rationale that any potential association between the
rocedure and exercise function should be reflected in
ardiac physiology. Linear regression was used to assess the
elationship between continuous variables, independent-
amples t test to compare normally distributed continuous
ariables between groups, Wilcoxon rank sum test to com-
are continuous variables with a skewed distribution, and
isher exact test to compare categorical variables. Exercise
unctional parameters were also compared with average
mean percent predicted value  100%) using 1-sample t
est. z-Scores were compared with normal (value 0) using
1-sample t test. SPSS (version 16, SPSS Inc., Chicago,llinois) was used for statistical analysis. desults
emographic and catheterization data. Recruitment let-
ers were sent to the last available address for 183 potentially
ligible patients identified in the cardiology database. Of
hese, 81 were contacted by telephone (conversation or voice
ail message); 41 enrolled in the study. The median age at
D in these 41 patients was 2.9 months (1 day to 27 years),
nd 28 (68%) were under 1 year; 18 patients (44%) were
ale. In 37 patients, balloon pulmonary valvuloplasty was
erformed at Children’s Hospital Boston; in the other 4
atients, the procedure was performed elsewhere, and care
as subsequently transferred to our institution. Balloon
alvuloplasty was performed between 1986 and 1990 in 9
atients (22%), 1991 and 1999 in 27 (66%), and in 2000 or
ater in 5 (12%). At the time of intervention, the median
ulmonary annulus diameter z-score was 1.0 (3.4 to
.7), and the median BAR was 1.3 (1.0 to 2.0). BAR was
nversely related to pulmonary valve z-score (n 34, R 0.67,
 0.001). Additional data are summarized in Table 1.
Four patients underwent repeat BD, 3 within 1 year of
he initial procedure and 1 who underwent the first proce-
ure during infancy and the second 4 years later.
ollow-up. The median age at testing was 14.4 years (7.7
o 47.2 years), and the median time interval from balloon
alvuloplasty was 13.1 years (6.2 to 22.9 years). In 37
atients, CMR and exercise testing were performed on the
ame day; the longest duration between the 2 tests in any
atient was 3 months. One patient did not consent to
xercise testing. Three patients had TR fraction 20%.
R. The median PR fraction was 10% (1% to 45%), and
he median PR volume index was 5.3 ml/m2/beat (0.5 to
0.2 ml/m2/beat). There was a very close correlation be-
ween PR volume index and PR fraction (R  0.98, p 
.001). Fourteen patients (34%) had a PR fraction 15%; 7
10%) had a PR fraction 30%; and 2 (4.9%) had a PR
raction 40%.
Among demographic and procedural factors, larger BAR
R  0.36, p  0.001) and younger age (ln-transformed) at
ntervention (R  0.47, p  0.002) were associated with
igher PR fraction (Fig. 1). PR fraction was not related to
uration between valvuloplasty and subsequent testing (p 
.91), year of intervention (p  0.96), or the degree of RV
ypertension prior to valve dilation (p  0.10).
The mean BAR was higher in the 14 patients with a PR
raction 15% than in those with a PR fraction 15% (1.42 
.23 vs. 1.21  0.17, p  0.008). BAR 1.4 was associated
ith a significantly higher risk of PR fraction 15% (odds
atio: 4.5 [1.4 to 14.5], p  0.01); the median PR fraction
mong patients with a BAR 1.4 was 26%. A PR fraction
15% was significantly more common in patients who
nderwent valvuloplasty at 1 year of age (12 of 26
atients) than those who were 1 year of age (2 of 15; odds
atio: 1.7 [1.1 to 2.5], p  0.03).
entricular volume and function. The mean RV end-
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Long-Term PR After Pulmonary Valve Dilation March 9, 2010:1041–7ompared with z-score  0). The median value was 1.5
range 0.2 to 8.4). z-scores were unavailable in 6 patients
ue to small body surface area. In 14 patients (40%), RV
ilation was present (z-score 2); Figure 2. In 1 (3%), it
as severe (z-score 6); the BAR for this patient was 1.45.
edian values for RV and LV EF were 61% (46 to 77%)
nd 63% (55% to 78%), respectively. Other CMR data are
ummarized in Table 1.
By linear regression, PR fraction correlated well with
ndexed RV end-diastolic volume (R  0.79, p  0.001)
Fig. 3). It correlated inversely, and less well, with RV EF
R0.50, p 0.001) (Fig. 3). The RV EF was modestly
nd inversely related to the pre-intervention RV to systemic
ressure ratio (R0.43, p 0.006). The PR fraction was
ot significantly associated with LV factors such as EF,
ndexed end-diastolic volume, or indexed stroke volume.
xercise function. On exercise testing with metabolic
nalysis using cycle ergometry (n 34) or treadmill (n 6),
tudy subjects had peak VO2 and heart rate (% predicted)
hat were modestly, but significantly, lower than average
Table 1). Of the 13 patients with subnormal peak VO2, 9
69%) had a subnormal O2 pulse, suggesting an insufficient
troke volume response to exercise; only 1 patient had a
Catheterization, CMR, and Exercise DataTable 1 Catheterization, CMR, and Exercise
Catheterization (n  41)
Age at balloon dilation (yrs) 2
Pulmonary annulus (mm) 10
Pulmonary annulus z-score 0
Balloon size (mm) 13
Balloon to annulus ratio 1
RV:systemic pressure ratio (%) 111
CMR imaging (n  41)
PR percent
PR volume (indexed, ml/m2) 8
RV end-diastolic volume (indexed, ml/m2) 1
RV end-diastolic volume z-score (n  35) 1
RV stroke volume (indexed, ml/m2) 61
RV EF%
LV end-diastolic volume (indexed, ml/m2) 80
LV end-diastolic volume z-score (n  35) 0
LV stroke volume (indexed, ml/m2) 50
LV EF%
Exercise (n  40)
Peak VO2 (% predicted)
Peak work rate (% predicted)
O2 pulse (% predicted)
Peak HR (% predicted)
FVC (% predicted) 1
FEV1 (% predicted) 1
p values for the exercise data refer to percentage predicted values co
CMR cardiac magnetic resonance; EF  ejection fraction; FEV1 
LV  left ventricular; RV  right ventricular; VO2  oxygen consumptioubnormal heart rate. Mean VE/VCO2 slope was 27  4. fNone of the demographic or continuous CMR variables
orrelated with the percentage of predicted peak VO2 or
eak work. Body mass index correlated modestly with the
E/VCO2 slope (R0.41, p 0.009), but not with other
xercise outcomes. When PR fraction was dichotomized,
eak VO2 was found to be significantly higher in patients
ith a PR fraction 15% than in those in whom it was
15% (96  16% vs. 85  17%, p  0.03) (Fig. 4). There
as a trend towards a higher percentage of predicted peak
ork in patients with a PR fraction 15% as well (99 
0% vs. 86  24%, p  0.06) (Fig. 4).
iscussion
n this study, we prospectively evaluated 41 patients who
ad undergone balloon valvuloplasty for valvar PS a median
f 13 years earlier, with minimal residual outflow tract
bstruction, using CMR imaging and exercise testing. This
llowed us both to characterize the prevalence of PR and its
isk factors and to assess the long-term impact of PR on
ardiac and exercise function. In this cohort, the degree of
R and RV dilation ranged markedly, but severe PR and
V dilation were very uncommon. Larger BAR and
ounger age at intervention were associated with higher PR
Value
p ValueMedian
.5 0.2 (0 to 26.7)
.6 9.1 (4.0 to 21.7)
.2 1.0 (3.4 to 1.7)
.4 12 (6.0 to 30.0)
.2 1.3 (1.0 to 2.0)
0.6 110.2 (44.2 to 206.9)
3 10 (1 to 45)
.6 5.3 (0.5 to 30.2)
8 100 (63 to 205)
.9 1.5 (0.2 to 8.4)
4.3 56.7 (40.8 to 104.3)
61 (46 to 77)
2.6 77.9 (52.5 to 108.5)
.0 0.1 (2.3 to 2.3)
.5 49.2 (33.6 to 70.0)
63 (55 to 78)
7 90 (61 to 126) 0.006
2 93 (60 to 149) 0.14
7 96 (60 to 128) 0.66
97 (76 to 113) 0.001
3 99 (68 to 125) 0.54
5 100 (64 to 132) 0.85
with an average value of 100% (1- sample t test).


















































1045JACC Vol. 55, No. 10, 2010 Harrild et al.
March 9, 2010:1041–7 Long-Term PR After Pulmonary Valve Dilationilation and modestly with decreased RV function. Overall,
xercise cardiopulmonary function in this group was mod-
stly below average, perhaps as a consequence of impaired
bility to augment stroke volume. Patients with a PR
raction 15% had significantly lower peak VO2 than those
ith less PR. No significant association was found between
Figure 1 Factors at Catheterization and PR Fraction
(A) Balloon:annulus ratio and (B) ln (age at catheterization) versus pulmonary
regurgitation (PR) fraction. PR fraction 15% is shaded. In the regression
equations, PR% is expressed as a fraction.
Figure 2 Prevalence of RV Dilation
Distribution of right ventricular (RV) end-diastolic volume z-score.ehese variables using linear regression analysis, although this
ay have been due at least in part to the limited number of
nrolled patients.
Some degree of RV dilation in this group was common,
ut was usually mild. The correlation between PR and
ndexed RV end-diastolic volume was fairly close, suggest-
ng that RV compliance does not vary widely over the range
f RV volumes seen in this group. In general, RV EF was
ormal, although there was a modest inverse relationship
ith PR fraction; this suggests that isolated PR and conse-
uent RV dilation may adversely impact RV function. LV
olume and function were also normal, and there was no
vidence of an inverse relationship between PR fraction or
V volume/function and LV stroke volume or EF. This
rovides evidence that, with modest degrees of PR and RV
ilation, there is unlikely to be significant ventricular inter-
ction. As a group, no relationship was seen between time
rom valvuloplasty and PR fraction. Changes in this value
ver time for a particular individual, however, were not
pecifically addressed.
These findings add to a growing body of literature on the
Figure 3 PR Fraction and RV Parameters on CMR Imaging
PR fraction versus (A) RV end diastolic volume (indexed) (RVEDVi) and (B) RV
ejection fraction (EF). In the regression equations, PR% is expressed as a frac-
tion. CMR  cardiac magnetic resonance; other abbreviations as in Figures 1












































































1046 Harrild et al. JACC Vol. 55, No. 10, 2010
Long-Term PR After Pulmonary Valve Dilation March 9, 2010:1041–7hat the impact of PR in this patient population was studied
n isolation, absent the many confounders present in other
opulations of patients with PR, such as those with repaired
etralogy of Fallot (26–30). Exercise data from our patients
iffer from those reported for patients with repaired tetral-
gy of Fallot in at least 2 respects. First, in contrast to the
ildly reduced peak VO2 observed in our patients, peak VO2
s often substantially diminished in patients with post-
perative tetralogy of Fallot (31). Second, whereas subjects
n our series on average had normal values of VE/VCO2
lope, patients with tetralogy of Fallot frequently have
levations of this value (32). In tetralogy patients, these
bnormalities are probably the result of ventilation/
erfusion mismatch secondary to pulmonary artery stenoses,
hich may further exacerbate PR and RV volume load
uring exercise. Such stenoses would be unexpected in the
atients in this series, and a more normal VE/VCO2 slope
as generally preserved.
In addition to offering insight into the pathophysiology of
hronic isolated PR, this study provides important long-
erm data on the outcomes of balloon pulmonary valvulo-
lasty, which has become the standard of care for treatment
f congenital valvar PS. The exclusion of patients with
Figure 4 PR Fraction and Exercise Parameters
Pulmonary regurgitation (PR) fraction versus percent predicted values of (A)
peak oxygen consumption (VO2) and (B) peak work. Subnormal ranges for exer-
cise parameters, as defined in the text, are shaded.ssociated anomalies or significant residual PS limits our ability to generalize these findings to the broader population
f patients who undergo BD for PS. Previous studies,
owever, have shown that residual or recurrent PS is
elatively uncommon, and that valvar PS is usually an
solated lesion (33,34). The study design also allowed the
ossibility of recruitment bias, although there is no obvious
eans by which this would dramatically alter our findings.
hus, although these factors must be taken into account and
ould in principle distort assessment of prevalence, we
nticipate that our findings are generally representative.
The target BAR for patients undergoing balloon pulmo-
ary valvuloplasty, 1.2 to 1.4, was based on experimental
tudies in which a BAR of 1.5 or higher was associated with
greater risk of damage to the RV outflow tract (35), later
ubstantiated in early human studies (12). In the current
tudy, the finding that significant PR was uncommon in
atients dilated with a BAR 1.4 provides support for the
ppropriateness of 1.2 to 1.4 as a target BAR range. In this
ohort, patients with a smaller pulmonary valve z-score were
ore likely to undergo dilation with a larger BAR, and
everal patients were treated with a BAR 1.4. In patients
ith recalcitrant obstruction, the tradeoff between using a
arger balloon in an effort to relieve PS compared with the
ncreased risk of complications and PR is important to
onsider and deserves further study.
tudy limitations. The power of our study and strength of
ts conclusions regarding the relationship between exercise
utcomes and PR fraction would have benefited from a
arger sample size or a higher burden of PR among enrolled
atients. Although an analysis of the effect of pre-
ntervention pressure load on long-term outcomes was
ncluded in this study, the impact of the duration of the load
as not specifically assessed, and bears further evaluation.
ur findings may be confounded by the coexistence of TR,
nother cause of RV volume loading, with PR. However,
he impact of TR was probably minimal in this cohort,
iven its low prevalence. The low percentage of eligible
atients who enrolled may introduce bias and, as discussed
bove, complicates accurate estimation of the overall prev-
lence of PR and RV dilation. However, this factor is
nlikely to have an important effect on the study’s primary
ims.
onclusions
ercutaneous pulmonary valvuloplasty yields a substantial
ong-term prevalence of PR and mild RV dilation. In this
eries, 34% of patients had a PR fraction 15% and 40%
ad an RV end-diastolic volume z-score 2. Severe PR or
V dilation, however, was very uncommon. Of the 41
atients, only 2 had PR fraction 40% and 1 had RV
nd-diastolic z-score 6. The BAR in each of these cases
as 1.4. PR was associated closely with RV dilation and
odestly with RV function. No significant relationship was
ound in linear regression analysis between PR fraction
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March 9, 2010:1041–7 Long-Term PR After Pulmonary Valve Dilation15%, however, had significantly lower peak VO2 than
he group with PR fraction 15%. This finding provides
vidence that significant PR, in the absence of confound-
ng cardiac comorbidities, is associated with reduced
xercise tolerance.
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